Target intelligence / Profile preview

UPK3BL-RASA4 readthrough transcript (ENSG00000205236)

Target
ENSG00000205236
Molecular classification
Other (readthrough/novel transcript, not classified as a canonical molecular target such as receptor, enzyme, ion channel, etc.)
01

Overview

The "UPK3BL-RASA4 readthrough" (ENSG00000205236) is a predicted gene fusion transcript resulting from a readthrough event between the adjacent UPK3BL and RASA4 genes on chromosome 7. Readthrough transcripts generally arise from transcription extending beyond the normal termination site of one gene into a neighboring gene. These transcripts are often annotated by automated genome annotation projects but rarely encode functional or physiologically relevant proteins, and there is no evidence in the published literature supporting a biological function or disease relevance for this specific readthrough. The component genes have known functions: RASA4 encodes a Ras GTPase-activating protein involved in signal transduction pathways, while UPK3BL is a poorly characterized gene of the uroplakin family. However, the fused readthrough product itself is not established as a functional protein, receptor, or therapeutic target. These types of predicted or computational transcripts are generally excluded from lists of valid molecular drug targets.

Other names
UPK3BL-RASA4 readthroughENSG00000205236May appear with Ensembl or NCBI gene IDs as alternative names

Beyond the preview

Go deeper on UPK3BL-RASA4 readthrough transcript (ENSG00000205236).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on UPK3BL-RASA4 readthrough transcript (ENSG00000205236).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call